Skip to main content

Table 2 WES and WGS SKAT-O results and the internal replication in the other data set

From: Whole-exome sequencing identifies novel protein-altering variants associated with serum apolipoprotein and lipid concentrations

    

Discovery

Replication

Gene

Gene position

Type

Pheno

N

Nvar

P

N

Nvar

P

Discovery study: WGS

 DEFT1P/ DEFT1P2

8:7006280-7008824

PTV

VLDLPL XL

187

1

1.3×10−6

   

 SBDS

7:66987676-66995696

PTV

apoC-III

294

2

5.0×10−6

   

 RBM47

4:40423254-40629866

PAV

apoC-III

294

3

2.0×10−6

323

1

0.398

 TRMT5

14:60971448-60981690

PAV

CHOL

329

8

3.5×10−6

419

4

0.322

   

VLDLPL XS

329

8

5.9×10−6

419

4

0.015

   

IDLFC

329

8

6.8×10−6

419

4

0.019

   

LDLC L

329

8

9.3×10−6

419

4

0.436

 CCAR1

10:68721143-68792377

PAV

VLDL XL

329

2

7.4×10−6

419

3

0.555

 CYP3A43

7:99828012-99866106

PAV

LDLCE M

329

6

8.7×10−6

419

3

0.067

   

LDLCE L

329

6

8.7×10−6

419

3

0.038

   

LDL M

329

6

9.2×10−6

419

3

0.074

 DIPK1A

1:92832728-92961522

PAV

TG

451

4

9.9×10−6

469

3

0.848

Discovery study: WES

 PTGER3

1:70852352-71047808

PTV

HDLFC M

419

1

9.8×10−6

329

1

0.119

 AKAP3

12:4615507-4649047

PAV

VLDLTG XXL

304

5

6.0×10−7

245

5

0.766

 TTYH1

19:54415430-54436719

PAV

HDLCE L

419

3

5.7×10−6

   

 ATP4A

19:35550192-35563658

PAV

HDLTG XL

419

3

8.1×10−6

329

3

0.810

  1. All genes reaching a suggestive p-value <1×10−5 are shown. P-values <2.9×10−6 for PAVs, and p-values <10−5 for PTV burden were defined as statistically significant, highlighted in italics; in replication, p-values <0.05 are highlighted in italics
  2. Discovery exome-wide analysis of either WGS or WES data, Replication for WGS, replication in WES data; for WES, replication in WGS data, Gene position chromosome number:start-end; if multiple gene isoforms exist, only one set of coordinates are given, Type burden of PAVs or PTVs, Nvar number of variants of the given variant type in the gene in discovery/ replication data, apoC-III serum apolipoprotein C-III, CHOL total cholesterol, TG triglycerides, HDLCE L cholesterol ester in large HDL, HDLFC M free cholesterol in medium HDL, HDLTG XL TG in extra-large HDL, IDLFC free cholesterol in IDL particles, LDL M total lipids in medium LDL, LDLC L cholesterol in large LDL, LDLCE M/L cholesterol esters in medium/large LDL, VLDL XL total lipids in extra-large VLDL, VLDLPL XS/XL phospholipid in extra small/extra-large VLDL, VLDLTG XXL TG in extremely large VLDL